These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31570248)

  • 1. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
    Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
    Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
    Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
    Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
    Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B
    World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.
    Yu KJ; Keskin SK; Meissner MA; Petros FG; Wang X; Borregales LD; Gu C; Tamboli P; Matin SF; Wood CG; Karam JA
    Cancer; 2018 Oct; 124(20):4023-4031. PubMed ID: 30276798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy.
    Kuusk T; Klatte T; Zondervan P; Lagerveld B; Graafland N; Hendricksen K; Capitanio U; Minervini A; Stewart GD; Ljungberg B; Horenblas S; Bex A
    World J Urol; 2021 Sep; 39(9):3377-3383. PubMed ID: 33634323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
    Wei Y; Wang M; Jin Y; Zhou C; Lyu J
    World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.
    Xiao R; Xu C; Ge L; He W; Yang B; Liu L; Liu C; Ma L
    Urol Int; 2021; 105(7-8):657-665. PubMed ID: 33882508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
    Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
    J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
    Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.
    Kuusk T; De Bruijn R; Brouwer OR; De Jong J; Donswijk M; Hendricksen K; Horenblas S; Jóźwiak K; Prevoo W; Valdés Olmos RA; Van Der Poel HG; Van Rhijn BW; Wit EM; Bex A
    Scand J Urol; 2018; 52(5-6):411-418. PubMed ID: 30526184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
    Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
    Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term survival analysis of 1 367 patients treated with radical nephrectomy from a single center].
    Zou XP; Ning K; Zhang ZL; Zou L; Xiong LB; Peng YL; Zhou ZH; Liu HM; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):981-987. PubMed ID: 37968085
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
    Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
    BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.